Furthermore, mutation of EGFR at Y1045 attenuated WJ-induced cell growth inhibition as well as its anti-cancer effect and EGFR degradation in vivo, suggesting the important role of EGFR in EGFR wt NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.